Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Frank Jessen, Peter Bartenstein et al.|The Lancet Neurology|2013Cited by 185
Interferon β-Mediated Protective Functions of Microglia in Central Nervous System AutoimmunityStefanie Scheu, Judith Alferink|International Journal of Molecular Sciences|2019Cited by 62